Intrinsic Value of S&P & Nasdaq Contact Us

Oramed Pharmaceuticals Inc. ORMP NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
69/100
4/7 Pass
SharesGrow Intrinsic Value
$37.98
+894.2%

Oramed Pharmaceuticals Inc. (ORMP) has 20 known insider and institutional holders on record. The largest holder is Lee James G with 10,069,013 shares. Other notable holders include Bronfeld Zeev and KIDRON NADAV.

Over the last 12 months, insiders have made 25 transactions in ORMP stock — 17 buys (valued at $1.44K) and 0 sells (valued at RSU Award). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.

ORMP Insider Ownership

Top Holder
Lee James G
10,069,013 shares
Buys (12 mo)
17
$1.44K value
Sells (12 mo)
0
$0.00 value
12-Month Transaction Activity
Buy 68%
Sell 0%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Lee James G CEO 10,069,013 2004-06-03
100%
2 Bronfeld Zeev 10 Percent Owner 5,808,517 2011-10-05
58%
3 Kidron Nadav President and CEO 3,422,243 2026-03-31
34%
4 Hexter Joshua COO & Cbo 1,160,384 2026-03-18
12%
5 Kidron Miriam Chief Scientific Officer 1,133,138 2026-03-31
11%
6 Orlev Chaime CFO, Treasurer and Secretary 828,000 2008-10-16
8%
7 Gabay Avraham Chief Financial Officer 745,145 2026-03-18
7%
8 Silberman David Chief Financial Officer 366,500 2024-01-08
4%
9 Li Xiaopeng Director 206,350 2017-08-03
2%
10 Mayer Arie Director 163,109 2026-01-05
2%
11 Derovan Netanel Chief Legal Officer 149,500 2023-05-31
1%
12 Rozov Yadin Director 146,500 2024-01-08
1%
13 Sank Leonard Director 128,021 2025-06-09
1%
14 Rabinowitz Michael Chief Commercial Officer 126,143 2023-01-04
1%
15 Shapiro Benjamin Director 119,720 2026-01-05
1%
16 Aghion Daniel Director 107,191 2026-01-02
1%
17 Reznick Yehuda Director 98,930 2026-01-05
1%
18 Rakin Kevin Director 46,661 2022-03-22
0%
19 Law Ronald Edward Chief Strategy Officer 37,152 2017-03-21
0%
20 Eisenberg Hilla CFO, Treasurer and Secretary 37,000 2019-02-28
0%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-03-30 Kidron Miriam Chief Scientific Officer Tax Withholding of RSU 435,084 $3.31 $1.44M
2026-03-30 Kidron Nadav President and CEO Tax Withholding of RSU 44,818 $3.31 $148.35K
2026-03-17 Gabay Avraham Chief Financial Officer RSU Award 95,889 - -
2026-03-17 Hexter Joshua COO & Cbo RSU Award 95,889 - -
2026-03-17 Kidron Miriam Chief Scientific Officer RSU Award 119,558 - -
2026-03-17 Kidron Nadav President and CEO RSU Award 167,005 - -
2026-03-12 Kidron Nadav President and CEO Gift (Given) 100,000 - -
2026-01-22 Gabay Avraham Chief Financial Officer Option Exercise (Sell) 19,000 - -
2026-01-22 Hexter Joshua COO & Cbo Option Exercise (Sell) 19,000 - -
2026-01-22 Kidron Miriam Chief Scientific Officer Option Exercise (Sell) 19,000 - -
2026-01-22 Kidron Nadav President and CEO Option Exercise (Sell) 109,000 - -
2026-01-14 Kidron Miriam Chief Scientific Officer Gift (Given) 86,166 - -
2025-12-31 Reznick Yehuda Director RSU Award 30,000 $0.01 $360.00
2025-12-31 Shapiro Benjamin Director RSU Award 30,000 $0.01 $360.00
2025-12-31 Mayer Arie Director RSU Award 30,000 $0.01 $360.00
2025-12-31 Hexter Joshua COO & Cbo RSU Award 19,000 - -
2025-12-31 Kidron Miriam Chief Scientific Officer RSU Award 19,000 - -
2025-12-31 Kidron Nadav President and CEO RSU Award 109,000 - -
2025-12-31 Aghion Daniel Director RSU Award 30,000 $0.01 $360.00
2025-12-31 Gabay Avraham Chief Financial Officer RSU Award 19,000 - -
2025-06-05 Reznick Yehuda Director RSU Award 30,000 - -
2025-06-05 Aghion Daniel Director RSU Award 30,000 - -
2025-06-05 Shapiro Benjamin Director RSU Award 30,000 - -
2025-06-05 Mayer Arie Director RSU Award 30,000 - -
2025-06-05 Sank Leonard Director RSU Award 30,000 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message